Results 181 to 190 of about 210,587 (243)
Pattern of disease recurrence and outcomes after progression of high-risk renal cell carcinoma (RCC) patients treated with adjuvant immunotherapy. [PDF]
Ciccarese C +19 more
europepmc +1 more source
NiFe‐NO3 Layered Double Hydroxide as a Novel Anode for Sodium Ion Batteries
This study demonstrates, for the first time, the effectiveness of using LDH as an anodic material in SIB. The material is stable and show high specific capacity, the reaction mechanism has been thoroughly investigated and comprehensively described and involves a phase change reaction followed by sodium intercalation.
Marco Fortunato +4 more
wiley +1 more source
Retraction Note: Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis. [PDF]
Damiano V +12 more
europepmc +1 more source
Abstract Among the Porphyridium genus, Porphyridium marinum exhibits the highest phycoerythrin (PE) content. In this study, the metabolic trade‐off between biomass, PE, and sulfated exopolysaccharide (EPS) production was assessed under varying nitrogen and sulfur availability, light intensity, residence time, and cultivation mode.
Rosaria Tizzani +3 more
wiley +1 more source
Evolving Paradigms in Lumbar Disc Herniation: From Prediction to Precision Surgery. [PDF]
Vadalà G +1 more
europepmc +1 more source
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk +5 more
wiley +1 more source
Neuronal injury biomarkers GFAP and neurofilament light chains (NfL) are associated with neurotoxicity and endothelial dysfunction in adult patients treated with antiCD19 CART cells. [PDF]
Galli E +11 more
europepmc +1 more source
Abstract Aim Local investigators (LIs) overestimate the objective response rate (ORR) in comparison to Blinded Independent Central Reviewers (BICR) in oncology. In this study, we re‐analysed data obtained in the PHEREXA trial (NCT01026142) with the following aims: i) to confirm at the single‐patient level the discrepancy observed by analysing ...
Gennaro Daniele +3 more
wiley +1 more source

